2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling.
about
Homology modeling a fast tool for drug discovery: current perspectives.The histidine-phosphocarrier protein of the phosphoenolpyruvate: sugar phosphotransferase system of Bacillus sphaericus self-associates.Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic painFrom laptop to benchtop to bedside: structure-based drug design on protein targets.Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.Biased signaling: potential agonist and antagonist of PAR2.Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.Mastering tricyclic ring systems for desirable functional cannabinoid activity.Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7.Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models.High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagyActivation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post-ischemic pain model of complex regional pain syndrome type I in rats.
P2860
Q30424335-A0966970-1AF7-4E4C-94A0-68790C2FC493Q31125880-E7802184-4B12-4219-9EA9-3B9E974D58D9Q34118976-2F821BC0-CE48-478D-810E-EA35721520DBQ34153589-63051ABE-CF72-41A5-8765-0E5D191A0DE0Q34561020-B2FACB80-081E-4ECE-A278-1F2B6AB56FF6Q35752199-8F1905FD-3E2C-42A3-BC6E-8BF2702FBDB0Q35907148-88E3311E-162F-413A-9D3F-3D35972D6262Q37539924-484025C2-C3E4-4581-9798-A261BAC59F8DQ37559812-6CF1FFB6-0A98-4B63-86F7-BEF70E68A0E0Q37695142-0C736BE2-DDEE-42A0-9CC8-F6AEC40911CCQ38842238-0A99E745-473F-4707-B16D-B016A9F44381Q38976083-C2B5A560-6789-4EF3-9591-34D584061A32Q38999747-B1739110-5CC8-4AD3-8497-086FA92C63BDQ51417508-32F75D10-00A1-441F-9A6F-2653430AB622
P2860
2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
2,3-Dihydro-1-benzofuran deriv ...... rough ligand-steered modeling.
@ast
2,3-Dihydro-1-benzofuran deriv ...... rough ligand-steered modeling.
@en
type
label
2,3-Dihydro-1-benzofuran deriv ...... rough ligand-steered modeling.
@ast
2,3-Dihydro-1-benzofuran deriv ...... rough ligand-steered modeling.
@en
prefLabel
2,3-Dihydro-1-benzofuran deriv ...... rough ligand-steered modeling.
@ast
2,3-Dihydro-1-benzofuran deriv ...... rough ligand-steered modeling.
@en
P2093
P2860
P921
P356
P1433
P1476
2,3-Dihydro-1-benzofuran deriv ...... hrough ligand-steered modeling
@en
P2093
Charles M Thompson
Fanny Astruc-Diaz
Frank R Fronczek
Mohamed Naguib
Philippe Diaz
Sharangdhar S Phatak
P2860
P304
P356
10.1002/CMDC.200900226
P577
2009-10-01T00:00:00Z